GlassScriptPhysician profile
Joseph Daniel Watts
NPI 1871123794
$9,405.16
in general payments reported to CMS, 2019-2025
46 companies · $1,929 in 2025
The $1,929 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,373 · 2022: $1,517 · 2023: $2,061 · 2024: $2,525 · 2025: $1,929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,515.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,361.86 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $899.32 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $890.40 | 2021-2025 | Jardiance |
| Boston Scientific Corporation | $685.70 | 2022-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
| Astrazeneca Pharmaceuticals LP | $633.90 | 2021-2025 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $566.46 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $547.23 | 2021-2025 | Verquvo |
| Pfizer INC. | $393.77 | 2022-2025 | |
| Esperion Therapeutics, INC. | $294.52 | 2021-2025 | Nexletol |
| Amgen INC. | $279.81 | 2021-2024 | Repatha |
| Irhythm Technologies, INC. | $258.91 | 2021-2024 | Zio Monitor, Zio Xt Patch |
| Abiomed | $253.68 | 2024-2025 | Impella |
| Scpharmaceuticals INC. | $243.91 | 2023-2024 | |
| Medtronic, INC. | $229.20 | 2021-2025 | Linq II, Micra |
| Atricure, INC. | $183.16 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $167.20 | 2022-2025 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $159.09 | 2021-2024 | |
| Actelion Pharmaceuticals US, INC. | $157.11 | 2021-2024 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $145.70 | 2022-2025 | |
| Lexicon Pharmaceuticals, INC. | $116.05 | 2023-2024 | Inpefa |
| Amarin Pharma, INC. | $86.63 | 2021-2022 | |
| Daiichi Sankyo INC. | $79.14 | 2021-2023 | Injectafer |
| Bridgebio Pharma, INC. | $59.42 | 2025 | Attruby |
| Impulse Dynamics (USA) INC. | $56.28 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $54.30 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $51.77 | 2025 | Onpattro |
| Kowa Pharmaceuticals America, INC. | $49.51 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $48.44 | 2023-2024 | Evkeeza |
| Kestra Medical Technology Services, INC. | $45.24 | 2024 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $35.11 | 2023 | Arcalyst |
| Novo Nordisk INC | $34.80 | 2021 | |
| Cardiva Medical, INC. | $34.04 | 2025 | Savvywire |
| Biosense Webster, INC. | $32.53 | 2025 | Carto 3 |
| Baxter Healthcare | $30.51 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Vital Connect, INC | $29.30 | 2023 | Vitalpatch Rtm |
| G Medical Diagnostic Services, INC. | $25.06 | 2022 | |
| Celgene Corporation | $23.62 | 2024 | Camzyos |
| Endologix LLC | $21.98 | 2024 | Endocross Device, Torus Stent Graft System |
| Biotronik INC. | $21.52 | 2022 | |
| Abbott Laboratories | $20.55 | 2023 | Merlin@Home |
| Glaxosmithkline, LLC. | $20.31 | 2025 | Arexvy, Shingrix |
| Agepha Pharma Fz LLC | $17.45 | 2025 | Lodoco |
| Inspire Medical Systems, INC. | $17.11 | 2023 | Inspire |
| Philips North America LLC | $14.76 | 2023 | |
| Cvrx, INC. | $14.50 | 2022 | |
| Altathera Pharmaceuticals LLC | $14.30 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Watts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.